PBL Pharma division has designed a customizable and highly innovative isolator able to completely automate different ATMPs production processes, which are, up to now, only manually performed by research institutes and pharmaceutical workshops.
The 100% class A system, completely sterilizable through VHP (or similar), allows to automate an ATMPs production process, already approved in clinic or in an advanced development/preclinical phase, without significant changes in the productive process.
PBL solution allows to make the scale-up of a specific ATMP and to transfer it widely, maintaining the same quality standards and increasing the production capacity.